Watertown biotech plans first clinical trial of weeklong schizophrenia drug

Watertown-based startup Lyndra Therapeutics is planning to launch its first clinical trial next year after early testing showed its science could turn a once-daily pill into a weekly treatment. Lyndra is testing a new science that can extend chronic oral medications from a once-daily treatment to a weekly regimen. The three-year-old biotech startup originated out of MIT professor Bob Langer's lab and has received support from the Bill and Melinda Gates Foundation. The company announced Thursday…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news